Showing results (251-260 of 328) with videos related to
Sort By:
Pageof 33
JACC. Heart Failure|December 30, 2014
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failureRobert J Mentz, Susanna R Stevens, Adam D DeVore, et al.Journal of Cardiac Failure|July 26, 2015
Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart FailureJustin L Grodin, Susanna R Stevens, Lisa de las Fuentes, et al.JAMA|January 3, 2013
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trialsSana M Al-Khatib, Anne Hellkamp, Gust H Bardy, et al.Journal of the American Heart Association|December 19, 2018
High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research NetworkMarat Fudim, Andrew P Ambrosy, Jie-Lena Sun, et al.American Heart Journal|July 22, 2020
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart ValveOliver K Jawitz, Tracy Y Wang, Renato D Lopes, et al.Circulation. Heart Failure|July 7, 2023
Background Medical Therapy and Clinical Outcomes From the VICTORIA TrialJustin A Ezekowitz, Ciaran J McMullan, Cynthia M Westerhout, et al.Circulation|May 22, 2023
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical TrialStephen J Greene, Eric J Velazquez, Kevin J Anstrom, et al.American Heart Journal|July 29, 2014
Independent data monitoring committees: preparing a path for the futureConnie N Hess, Matthew T Roe, C Michael Gibson, et al.JAMA|August 23, 2017
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialG Michael Felker, Kevin J Anstrom, Kirkwood F Adams, et al.JAMA Cardiology|March 30, 2017
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical TrialPatricia A Cowper, Shubin Sheng, Renato D Lopes, et al.Pageof 33